Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay

Clinical Cancer Research

Volumn 15, Issue 8, 2009, Pages 2879-2884

  YasuhiroTamaki, ^a   Akiyama, Futoshi ^b   Iwase, Takuji ^h   Kaneko, Tomoyo ^b   Tsuda, Hitoshi ^b   Sato, Kazuhiko ^j   Ueda, Shigeto ^j   Mano, Masayuki ^b   Masuda, Norikazu ^c   Takeda, Masashi ^b   Tsujimoto, Masahiko ^b   KatsuhideYoshidome, ^d   Inaji, Hideo ^b   Nakajima, Hiromu ^b   Komoike, Yoshifumi ^b   Kataoka, Tatsuki R ^e   Nakamura, Seigo ^b   Suzuki, Koyu ⁱ   KoichiroTsugawa, ^b   Wakasa, Kenichi ^f   Okino, Tsuyoshi ^g   Kato, Yo ^b   Noguchi, Shinzaburo ^a,k   Matsuura, Nariaki ^a   more..

^a OSAKA UNIVERSITY   (Japan)

^b Graduate School of Medicine and Health Science ^*  (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d OSAKA POLICE HOSPITAL   (Japan)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^f OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g OSAKA UNIVERSITY   (Japan)

^h CANCER INSTITUTE HOSPITAL   (Japan)

ⁱ ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^j NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^k OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKERATIN 19;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; VALIDATION STUDY;

BREAST; BREAST NEOPLASMS; HUMANS; KERATIN-19; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 65249121389     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-1881     Document Type: Article

References (28)

1. Turner RR, Ollila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999;23:263-7.
2. Motomura K, Komoike Y, Inaji H, et al. Multiple sectioning and immunohisto-chemical staining of sentinel nodes in patients with breast cancer. Br J Surg 2002;89:1032-4.
3. Veronesi U, Zurrida S, Mazzarol G. Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg2001;25:806-8.
4. Fortunato L, Amini M, Costarelli L, Piro FR, Farina M, Vitelli CE. A standardized sentinel lymph node enhanced pathology protocol (SEEP) in patients with breast cancer. J Surg Oncol 2007;96:470-3.
5. Dowlatshahi K, Fan M, Anderson JM, Bloom KJ. Occult metastases in sentinel lymph nodes of 200 patients with operable breast cancer. Ann Surg Oncol 2001;8:675-81.
6. Turner RR, Giuliano AE, Hoon DS, Glass EC, Krasne DL. Pathologic examination of sentinel lymph node for breastcarcinoma.World J Surg 2001;25:798-805.
7. Blumencranz P,Whitworth PW, Deck K, et al. Sentinel node staging for breast cancer: intraoperative molecular pathology overcomes conventional histologic sampling errors. Am J Surg 2007;194:426-32.
8. Viale G, Dell'Orto P, Biasi MO, et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription- polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg 2008;247:136-42.
9. Julian TB, Blumencranz P, Deck K, et al. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J Clin Oncol 2008;26:3338-45.
10. Mansel RE, Goyal A, Douglas-Jones A, et al. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time Gene-Search BLN assay in the operating room: results of the Cardiff study. Breast Cancer Res Treat 2008 [Epub ahead of print].
11. Notomi T, Okayama H, asubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000;28:E63.
12. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007;13:4807-16.
13. Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 2008;122:2562-7.
14. Noguchi S,AiharaT, Nakamori S,et al.The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcription- polymerase chain reaction. Cancer1994;74:1595-600.
15. Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res1999;59:3028-31.
16. Masuda N,Tamaki Y, Sakita I, et al. Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription- polymerase chain reaction in breast cancer. Clin Cancer Res 2000;6:4176-85.
17. Wascher RA, Bostick PJ, Huynh KT, et al. Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes. Br J Cancer 2001;85:1340-6.
18. Mitas M, Mikhitarian K, Walters C, et al. Quantitative real-time RT-PCR detection of breast cancer micrometastasis usinga multigene marker panel. Int J Cancer 2001;93:162-71.
19. Manzotti M,Dell'OrtoPD, MaisonneuveP,etal. Reverse transcription- polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer 2001;95:307-12.
20. Hughes SJ, Xi L, Raja S, et al. A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer. Ann Surg2006;243:389-98.
21. Gillanders WE, Mikhitarian K, Hebert R, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis. Ann Surg 2004;239:828-40.
22. Mikhitarian K, Martin RH, Mitas M, et al. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery 2005;138:474-81.
23. Backus J, Laughlin T, Wang Y, et al. Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis. J Mol Diagnosis 2005;7:327-36.
24. Ruud P, Fodstad Ø, Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 1999;80:119-25.
25. Bleiweiss IJ, Nagi CS, Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol 2006;24:2013-8.
26. Schwartz GF, Giuliano AE,Veronesi U; Consensus Conference Committee. Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia,PA,USA. Cancer2002;94:2542-51.
27. Bartek J, Taylor-Papadimitriou J, Miller N, Mills R. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissue and tumors. Int J Cancer 1985;36:299-306.
28. Parikh RR, Yang Q, Higgins S, Haffty BG. Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK 19 expression. Int J Radiat Oncol Biol Phys 2007;70:35-42.